Lanean...
Delivery of nucleic acid therapeutics for cancer immunotherapy
Cancer immunotherapy has shown great potential as witnessed by an increasing number of immuno-oncology drug approvals in the past few years. Meanwhile, the field of nucleic acid therapeutics has made significant advancement. Nucleic acid therapeutics, such as plasmids, antisense oligonucleotides (AS...
Gorde:
| Argitaratua izan da: | Med Drug Discov |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8320672/ https://ncbi.nlm.nih.gov/pubmed/34337382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medidd.2020.100023 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|